Tracey Mullen

Senior Vice President of Operations at Abveris Antibody, a Division of Twist Bioscience

 Tracey Mullen is a chemical-biological engineer from MIT who began her career as an Antibody Discovery Scientist at a startup contract research organization specializing in in vivo antibody discovery. In 2013, she joined the Antibody Discovery team at Biogen where she helped implement the technology transfer of the Adimab yeast display platform. In June of 2018, Tracey joined Abveris as the Chief Operating Officer, and is now the SVP of Operations managing for in vivo discovery campaigns.